Skip to Content


In the US, TOBI (tobramycin systemic) is a member of the following drug classes: aminoglycosides, inhaled anti-infectives and is used to treat Bacteremia, Bacterial Infection, Bone infection, Burns - External, Cystic Fibrosis, Endocarditis, Febrile Neutropenia, Intraabdominal Infection, Kidney Infections, Meningitis, Peritonitis, Pneumonia, Rabbit Fever, Sepsis, Shunt Infection and Skin or Soft Tissue Infection.

US matches:

UK matches:

Ingredient matches for TOBI


Tobramycin is reported as an ingredient of TOBI in the following countries:

  • Argentina
  • Australia
  • Belgium
  • Brazil
  • Bulgaria
  • Canada
  • Colombia
  • Croatia (Hrvatska)
  • Cyprus
  • Czech Republic
  • Denmark
  • Estonia
  • Finland
  • France
  • Greece
  • Iceland
  • Ireland
  • Israel
  • Italy
  • Japan
  • Latvia
  • Lithuania
  • Macedonia
  • Malta
  • Mexico
  • Netherlands
  • New Zealand
  • Norway
  • Paraguay
  • Romania
  • Serbia
  • Slovakia
  • Spain
  • Sweden
  • Taiwan
  • Turkey
  • United Kingdom
  • United States

Tobramycin sulfate (a derivative of Tobramycin) is reported as an ingredient of TOBI in the following countries:

  • Bangladesh
  • Poland

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.